Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC.
Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life with HIV and Substance Use (ePORTAL HIV-S)
Roles of the N domain of the AAA+ Lon protease in substrate recognition, allosteric regulation and chaperone activity.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life with HIV and Substance Use (ePORTAL HIV-S)
Overview
sponsor award id
R01DA058965
Biography
contributor
Co-Principal Investigator
Time
start date
2023-08-15
end date
2027-06-30